Literature DB >> 22712056

Anatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian Striatum.

Kathy Steece-Collier1, David J Rademacher, Katherine Soderstrom.   

Abstract

The goal of researchers and clinicians interested in re-instituting cell based therapies for PD is to develop an effective and safe surgical approach to replace dopamine (DA) in individuals suffering from Parkinson's disease (PD). Worldwide clinical trials involving transplantation of embryonic DA neurons into individuals with PD have been discontinued because of the often devastating post-surgical side-effect known as graft-induced dyskinesia (GID). There have been many review articles published in recent years on this subject. There has been a tendency to promote single factors in the cause of GID. In this review, we contrast the pros and cons of multiple factors that have been suggested from clinical and/or preclinical observations, as well as novel factors not yet studied that may be involved with GID. It is our intention to provide a platform that might be instrumental in examining how individual factors that correlate with GID and/or striatal pathology might interact to give rise to dysfunctional circuit remodeling and aberrant motor output.

Entities:  

Year:  2012        PMID: 22712056      PMCID: PMC3375918          DOI: 10.1016/j.baga.2012.01.002

Source DB:  PubMed          Journal:  Basal Ganglia        ISSN: 2210-5336


  170 in total

1.  Mesoaccumbens dopamine neuron synapses reconstructed in vitro are glutamatergic.

Authors:  M P Joyce; S Rayport
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study).

Authors:  C Warren Olanow; Philippe Damier; Christopher G Goetz; Thomas Mueller; John Nutt; Olivier Rascol; Alexandru Serbanescu; Frieda Deckers; Hermann Russ
Journal:  Clin Neuropharmacol       Date:  2004 Mar-Apr       Impact factor: 1.592

3.  Evidence of a breakdown of corticostriatal connections in Parkinson's disease.

Authors:  B Stephens; A J Mueller; A F Shering; S H Hood; P Taggart; G W Arbuthnott; J E Bell; L Kilford; A E Kingsbury; S E Daniel; C A Ingham
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

4.  A metabolite of buspirone increases locus coeruleus activity via alpha 2-receptor blockade.

Authors:  G Engberg
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

5.  Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.

Authors:  Raúl de la Fuente-Fernández; Michael Schulzer; Lisa Kuramoto; Jacquelyn Cragg; Nandhagopal Ramachandiran; Wing L Au; Edwin Mak; Jess McKenzie; Siobhan McCormick; Vesna Sossi; Thomas J Ruth; Chong S Lee; Donald B Calne; A Jon Stoessl
Journal:  Ann Neurol       Date:  2011-01-18       Impact factor: 10.422

6.  Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies.

Authors:  J H Kordower; J M Rosenstein; T J Collier; M A Burke; E Y Chen; J M Li; L Martel; A E Levey; E J Mufson; T B Freeman; C W Olanow
Journal:  J Comp Neurol       Date:  1996-06-24       Impact factor: 3.215

7.  Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment.

Authors:  Rosalinda C Roberts; Michelle Force; Lili Kung
Journal:  Synapse       Date:  2002-08       Impact factor: 2.562

8.  Dopamine neurons mediate a fast excitatory signal via their glutamatergic synapses.

Authors:  Nao Chuhma; Hui Zhang; Justine Masson; Xiaoxi Zhuang; David Sulzer; René Hen; Stephen Rayport
Journal:  J Neurosci       Date:  2004-01-28       Impact factor: 6.167

9.  Intermittent L-DOPA treatment differentially alters synaptotagmin 4 and 7 gene expression in the striatum of hemiparkinsonian rats.

Authors:  Gordana Glavan
Journal:  Brain Res       Date:  2008-07-29       Impact factor: 3.252

10.  Cholinergic interneurons mediate fast VGluT3-dependent glutamatergic transmission in the striatum.

Authors:  Michael J Higley; Aryn H Gittis; Ian A Oldenburg; Nina Balthasar; Rebecca P Seal; Robert H Edwards; Bradford B Lowell; Anatol C Kreitzer; Bernardo L Sabatini
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

View more
  5 in total

Review 1.  The immunological challenges of cell transplantation for the treatment of Parkinson's disease.

Authors:  Amanda L Piquet; Kala Venkiteswaran; Neena I Marupudi; Matthew Berk; Thyagarajan Subramanian
Journal:  Brain Res Bull       Date:  2012-04-11       Impact factor: 4.077

2.  Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.

Authors:  Timothy J Collier; Jennifer O'Malley; David J Rademacher; Jennifer A Stancati; Kellie A Sisson; Caryl E Sortwell; Katrina L Paumier; Kibrom G Gebremedhin; Kathy Steece-Collier
Journal:  Neurobiol Dis       Date:  2015-03-11       Impact factor: 5.996

3.  Cell therapy for Parkinson's disease: Why it doesn't work every time.

Authors:  Timothy J Collier; Caryl E Sortwell; Natosha M Mercado; Kathy Steece-Collier
Journal:  Mov Disord       Date:  2019-06-24       Impact factor: 10.338

Review 4.  Interspecies Organogenesis for Human Transplantation.

Authors:  Andrew T Crane; Rajagopal N Aravalli; Atsushi Asakura; Andrew W Grande; Venkatramana D Krishna; Daniel F Carlson; Maxim C-J Cheeran; Georgette Danczyk; James R Dutton; Perry B Hackett; Wei-Shou Hu; Ling Li; Wei-Cheng Lu; Zachary D Miller; Timothy D O'Brien; Angela Panoskaltsis-Mortari; Ann M Parr; Clairice Pearce; Mercedes Ruiz-Estevez; Maple Shiao; Christopher J Sipe; Nikolas G Toman; Joseph Voth; Hui Xie; Clifford J Steer; Walter C Low
Journal:  Cell Transplant       Date:  2019-08-19       Impact factor: 4.064

5.  The BDNF Val66Met polymorphism (rs6265) enhances dopamine neuron graft efficacy and side-effect liability in rs6265 knock-in rats.

Authors:  Natosha M Mercado; Jennifer A Stancati; Caryl E Sortwell; Rebecca L Mueller; Samuel A Boezwinkle; Megan F Duffy; D Luke Fischer; Ivette M Sandoval; Fredric P Manfredsson; Timothy J Collier; Kathy Steece-Collier
Journal:  Neurobiol Dis       Date:  2020-11-11       Impact factor: 5.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.